Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
‘How to Change a Memory: One Neuroscientist’s Quest to Alter the Past,’ an excerpt
Part scientific exploration, part memoir, Steve Ramirez’s new book delves into the study of memory manipulation and his personal journey of discovery, friendship and grief.
‘How to Change a Memory: One Neuroscientist’s Quest to Alter the Past,’ an excerpt
Part scientific exploration, part memoir, Steve Ramirez’s new book delves into the study of memory manipulation and his personal journey of discovery, friendship and grief.
Journal retracts two papers evaluating ADHD interventions
Frontiers in Public Health retracted one paper for its “unacceptable level of similarity” to another paper, and the other over concerns about its “scientific validity.”
Journal retracts two papers evaluating ADHD interventions
Frontiers in Public Health retracted one paper for its “unacceptable level of similarity” to another paper, and the other over concerns about its “scientific validity.”
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.